Annual EBITDA
$36.03 M
-$4.29 M-10.64%
31 December 2023
Summary:
Organogenesis Holdings annual earnings before interest, taxes, depreciation & amortization is currently $36.03 million, with the most recent change of -$4.29 million (-10.64%) on 31 December 2023. During the last 3 years, it has fallen by -$1.20 million (-3.21%). ORGO annual EBITDA is now -58.58% below its all-time high of $87.00 million, reached on 31 December 2021.ORGO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$10.70 M
+$20.42 M+210.06%
30 September 2024
Summary:
Organogenesis Holdings quarterly earnings before interest, taxes, depreciation & amortization is currently $10.70 million, with the most recent change of +$20.42 million (+210.06%) on 30 September 2024. Over the past year, it has dropped by -$1.16 million (-9.75%). ORGO quarterly EBITDA is now -60.88% below its all-time high of $27.34 million, reached on 30 June 2021.ORGO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$12.12 M
-$1.16 M-8.71%
30 September 2024
Summary:
Organogenesis Holdings TTM earnings before interest, taxes, depreciation & amortization is currently $12.12 million, with the most recent change of -$1.16 million (-8.71%) on 30 September 2024. Over the past year, it has dropped by -$31.67 million (-72.32%). ORGO TTM EBITDA is now -87.03% below its all-time high of $93.49 million, reached on 30 June 2021.ORGO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.6% | -9.8% | -72.3% |
| 3 y3 years | -3.2% | -44.0% | -86.0% |
| 5 y5 years | +176.7% | +279.9% | +144.2% |
ORGO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -58.6% | at low | -56.5% | +210.1% | -86.1% | at low |
| 5 y | 5 years | -58.6% | +176.7% | -60.9% | +188.8% | -87.0% | +144.2% |
| alltime | all time | -58.6% | +176.7% | -60.9% | +158.6% | -87.0% | +125.8% |
Organogenesis Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.70 M(-210.1%) | $12.12 M(-8.7%) |
| June 2024 | - | -$9.72 M(-6850.0%) | $13.28 M(-63.3%) |
| Mar 2024 | - | $144.00 K(-98.7%) | $36.23 M(+0.5%) |
| Dec 2023 | $36.03 M(-10.6%) | $11.00 M(-7.2%) | $36.03 M(-17.7%) |
| Sept 2023 | - | $11.85 M(-10.4%) | $43.79 M(+20.3%) |
| June 2023 | - | $13.23 M(<-9900.0%) | $36.40 M(-3.8%) |
| Mar 2023 | - | -$54.00 K(-100.3%) | $37.83 M(-6.2%) |
| Dec 2022 | $40.32 M(-53.7%) | $18.76 M(+320.7%) | $40.32 M(-12.6%) |
| Sept 2022 | - | $4.46 M(-69.6%) | $46.13 M(-24.1%) |
| June 2022 | - | $14.66 M(+501.7%) | $60.76 M(-17.3%) |
| Mar 2022 | - | $2.44 M(-90.1%) | $73.44 M(-15.6%) |
| Dec 2021 | $87.00 M(+133.7%) | $24.57 M(+28.7%) | $87.00 M(+0.7%) |
| Sept 2021 | - | $19.09 M(-30.2%) | $86.41 M(-7.6%) |
| June 2021 | - | $27.34 M(+71.0%) | $93.49 M(+42.5%) |
| Mar 2021 | - | $15.99 M(-33.3%) | $65.63 M(+74.6%) |
| Dec 2020 | $37.23 M | $23.98 M(-8.4%) | $37.58 M(+129.9%) |
| Sept 2020 | - | $26.17 M(-5133.3%) | $16.34 M(-203.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$520.00 K(-95.7%) | -$15.77 M(-22.4%) |
| Mar 2020 | - | -$12.05 M(-539.7%) | -$20.34 M(+3.0%) |
| Dec 2019 | -$19.74 M(-58.0%) | $2.74 M(-146.1%) | -$19.74 M(-28.1%) |
| Sept 2019 | - | -$5.95 M(+17.0%) | -$27.45 M(-8.0%) |
| June 2019 | - | -$5.08 M(-55.6%) | -$29.84 M(-25.7%) |
| Mar 2019 | - | -$11.45 M(+130.1%) | -$40.17 M(-14.5%) |
| Dec 2018 | -$46.98 M(+5051.3%) | -$4.98 M(-40.3%) | -$46.96 M(+3.8%) |
| Sept 2018 | - | -$8.33 M(-45.9%) | -$45.23 M(+13.8%) |
| June 2018 | - | -$15.41 M(-15.5%) | -$39.75 M(+61.8%) |
| Mar 2018 | - | -$18.24 M(+461.9%) | -$24.56 M(+275.6%) |
| Dec 2017 | -$912.00 K(-48.0%) | -$3.25 M(+13.8%) | -$6.54 M(-47.0%) |
| Sept 2017 | - | -$2.85 M(+1186.3%) | -$12.34 M(+29.9%) |
| June 2017 | - | -$221.80 K(+1.5%) | -$9.50 M(+2.4%) |
| Mar 2017 | - | -$218.60 K(-97.6%) | -$9.28 M(+2.2%) |
| Dec 2016 | -$1.75 M | -$9.04 M(>+9900.0%) | -$9.07 M(>+9900.0%) |
| Sept 2016 | - | -$14.50 K(+2800.0%) | -$30.50 K(+90.6%) |
| June 2016 | - | -$500.00(-96.8%) | -$16.00 K(+3.2%) |
| Mar 2016 | - | -$15.50 K | -$15.50 K |
FAQ
- What is Organogenesis Holdings annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Organogenesis Holdings?
- What is Organogenesis Holdings annual EBITDA year-on-year change?
- What is Organogenesis Holdings quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly EBITDA year-on-year change?
- What is Organogenesis Holdings TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Organogenesis Holdings?
- What is Organogenesis Holdings TTM EBITDA year-on-year change?
What is Organogenesis Holdings annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ORGO is $36.03 M
What is the all time high annual EBITDA for Organogenesis Holdings?
Organogenesis Holdings all-time high annual earnings before interest, taxes, depreciation & amortization is $87.00 M
What is Organogenesis Holdings annual EBITDA year-on-year change?
Over the past year, ORGO annual earnings before interest, taxes, depreciation & amortization has changed by -$4.29 M (-10.64%)
What is Organogenesis Holdings quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ORGO is $10.70 M
What is the all time high quarterly EBITDA for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly earnings before interest, taxes, depreciation & amortization is $27.34 M
What is Organogenesis Holdings quarterly EBITDA year-on-year change?
Over the past year, ORGO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.16 M (-9.75%)
What is Organogenesis Holdings TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ORGO is $12.12 M
What is the all time high TTM EBITDA for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM earnings before interest, taxes, depreciation & amortization is $93.49 M
What is Organogenesis Holdings TTM EBITDA year-on-year change?
Over the past year, ORGO TTM earnings before interest, taxes, depreciation & amortization has changed by -$31.67 M (-72.32%)